Cure TV

Colleen Mabasa, a patient with multiple myeloma, discusses her CAR T-cell therapy journey and the pivotal role self-advocacy played in her care.

Prostate cancer survivors Ronald Wakefield and Ernie Strauss sat down for an interview with CURE.

Dave Coulier, who has become a vocal advocate during his cancer journeys, has launched a digital wellness platform, AwearMarket.

Wendy Brooks, a survivor of extensive-stage small cell lung cancer, and her husband and care partner, Larry Brooks, highlight the role of self-advocacy.

Dan, a pancreatic cancer survivor and advocate, shared insights on participating in clinical trials and the importance of self-advocacy.

Oya Gilbert, diagnosed with multiple myeloma in 2017, advises patients to bring someone to appointments, ask questions and seek second opinions.

CURE spoke with an expert about why a support system is crucial for patients with lung cancer.

CURE was on site at the 2025 ASH Annual Meeting, sharing expert conversations and patient-focused reporting that highlighted progress in blood cancer care.

Jace Yawnick explained why a support system is essential for patients with cancer.

As he faces cancer for the second time since 2024, actor Dave Coulier is incredibly aware of the power of positive thinking.

An expert discusses IL-18-armored CAR T cells for adults with relapsed B-cell leukemia, showing complete remissions with manageable side effects.

CURE spoke with a clinical psychologist about the stigmas often faced by patients with lung cancer.

Dan describes how early self-advocacy, second opinions and trial research helped him pursue experimental treatments that led to remission from stage 4 pancreatic cancer.

Jace Yawnick, now in remission from non-Hodgkin lymphoma, is navigating the world of mental health one day at a time.

Gastric cancer care highlights eating difficulties, weight loss and side effects showing why nutrition support and clinical trials are key

After beginning treatment for stage 3 inflammatory breast cancer, Lindsey Gunter started experiencing chemotherapy side effects so intense she was unable to walk.

Asian women who do not smoke in Northern California face rising lung cancer rates which are often diagnosed late due to current screening gaps.

CURE spoke with Dr. Dickran Kazandjian about why MRD matters for patients with multiple myeloma.

In a recent interview with CURE, Dr. Kai Tsao discussed treatment advancements for patients with prostate cancer.

Dr. Robert Orlowski says a single-drug option in newly diagnosed myeloma may offer strong responses with fewer side effects and preserve future treatments.

Real-time text check-ins helped physicians identify issues sooner and support quality of life for patients with myeloma at ASH 2025.

Dr. Thomas Marron explains how therapeutic vaccines differ from preventative vaccines in lung cancer care.

Dr. Amany Keruakous discussed how bispecific antibodies for multiple myeloma work by simultaneously targeting cancer cells and T cells.

Dr. Ajay Gupta of the Roswell Park Comprehensive Cancer Center discussed basics of gastrointestinal stromal tumors.

Dr. Daniel Peters discussed targeted therapies and regimens that patients with acute myeloid leukemia, or AML, should be aware of.

Dr. Girindra Raval sat down for an interview with CURE to discuss what patients with EGFR-mutated lung cancer should know about their treatment options.

Nona Baker, who was first diagnosed with a blood cancer in 1991, shares her experience with polycythemia vera.

Dr. Charles M. Rudin discussed recent treatment advancements for patients with small cell lung cancer.